scholarly article | Q13442814 |
P356 | DOI | 10.1002/2211-5463.12251 |
P8608 | Fatcat ID | release_qyodmzmknfcdvmaow5bbhxpiue |
P932 | PMC publication ID | 5536995 |
P698 | PubMed publication ID | 28781952 |
P50 | author | Bingli Wu | Q87596526 |
P2093 | author name string | Yue Li | |
Ying Zhu | |||
Haiying Zou | |||
Enmin Li | |||
Jianyi Wu | |||
Liyan Xu | |||
Chuhong Chen | |||
Simin Guo | |||
Wenming Xie | |||
Pixian Zhang | |||
Xinning Liu | |||
Zhennan Liao | |||
Zhoude Zheng | |||
P2860 | cites work | ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks | Q24570122 |
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources | Q27860739 | ||
Network biology: understanding the cell's functional organization | Q27861027 | ||
Specificity and stability in topology of protein networks | Q28216450 | ||
The BioGRID interaction database: 2015 update | Q28252221 | ||
C-terminal domain of SMYD3 serves as a unique HSP90-regulated motif in oncogenesis | Q28596567 | ||
Biological network exploration with Cytoscape 3 | Q28655509 | ||
Network medicine: a network-based approach to human disease | Q29547462 | ||
Topological analysis and interactive visualization of biological networks and protein structures | Q30414346 | ||
Cerebral: a Cytoscape plugin for layout of and interaction with biological networks using subcellular localization annotation. | Q33274604 | ||
Enrichment map: a network-based method for gene-set enrichment visualization and interpretation | Q33749961 | ||
Network based analyses of gene expression profile of LCN2 overexpression in esophageal squamous cell carcinoma | Q33789015 | ||
Towards the identification of protein complexes and functional modules by integrating PPI network and gene expression data | Q34279008 | ||
PEG1/MEST and IGF2 DNA methylation in CIN and in cervical cancer. | Q34351507 | ||
Integrating protein-protein interaction networks with phenotypes reveals signs of interactions. | Q34385589 | ||
SMYD3 links lysine methylation of MAP3K2 to Ras-driven cancer | Q34420873 | ||
Cooperation between SMYD3 and PC4 drives a distinct transcriptional program in cancer cells | Q36160685 | ||
Epigenetic silencing of miR-335 and its host gene MEST in hepatocellular carcinoma | Q36642863 | ||
Genetic screening for signal transduction in the era of network biology | Q36718781 | ||
Getting connected: analysis and principles of biological networks | Q36808436 | ||
Controllability analysis of the directed human protein interaction network identifies disease genes and drug targets | Q37173042 | ||
A SMYD3 Small-Molecule Inhibitor Impairing Cancer Cell Growth | Q37183416 | ||
Human Protein Reference Database and Human Proteinpedia as resources for phosphoproteome analysis. | Q37967156 | ||
DNA methylation-associated repression of MEST/PEG1 expression contributes to the invasion of extravillous trophoblast cells | Q38742718 | ||
SMYD3 stimulates EZR and LOXL2 transcription to enhance proliferation, migration, and invasion in esophageal squamous cell carcinoma | Q38786079 | ||
Upregulated SMYD3 promotes bladder cancer progression by targeting BCLAF1 and activating autophagy | Q38811194 | ||
SET and MYND domain-containing protein 3 is overexpressed in human glioma and contributes to tumorigenicity | Q38838915 | ||
YAP/TAZ at the Roots of Cancer. | Q38864941 | ||
SMYD3 contributes to a more aggressive phenotype of prostate cancer and targets Cyclin D2 through H4K20me3. | Q38874203 | ||
Induction of Chromosome Instability by Activation of Yes-Associated Protein and Forkhead Box M1 in Liver Cancer. | Q38935135 | ||
SMYD3 as an oncogenic driver in prostate cancer by stimulation of androgen receptor transcription | Q39068468 | ||
GATA3 acts upstream of FOXA1 in mediating ESR1 binding by shaping enhancer accessibility | Q39240915 | ||
SMYD3 promotes cancer invasion by epigenetic upregulation of the metalloproteinase MMP-9. | Q39423473 | ||
Knockdown of SMYD3 by RNA interference down-regulates c-Met expression and inhibits cells migration and invasion induced by HGF. | Q39868377 | ||
Cancer statistics in China, 2015. | Q40064386 | ||
Elevated Levels of SET and MYND Domain-Containing Protein 3 Are Correlated with Overexpression of Transforming Growth Factor-β1 in Gastric Cancer | Q41667134 | ||
SET and MYND domain-containing protein 3 decreases sensitivity to dexamethasone and stimulates cell adhesion and migration in NIH3T3 cells | Q42826871 | ||
Integrated network analysis platform for protein-protein interactions | Q43961965 | ||
Interaction and localization diversities of global and local hubs in human protein-protein interaction networks | Q50612850 | ||
Computing topological parameters of biological networks | Q51900389 | ||
Smyd3 Is a Transcriptional Potentiator of Multiple Cancer-Promoting Genes and Required for Liver and Colon Cancer Development | Q54212924 | ||
Histone methyltransferase SMYD3 promotes MRTF-A-mediated transactivation of MYL9 and migration of MCF-7 breast cancer cells. | Q54663444 | ||
X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization | Q80980462 | ||
P4510 | describes a project that uses | Cytoscape | Q3699942 |
P433 | issue | 8 | |
P921 | main subject | esophageal squamous cell carcinoma | Q108442577 |
P304 | page(s) | 1111-1125 | |
P577 | publication date | 2017-07-03 | |
P1433 | published in | FEBS Open Bio | Q27724062 |
P1476 | title | Network analyses elucidate the role of SMYD3 in esophageal squamous cell carcinoma | |
P478 | volume | 7 |
Search more.